文献速递胸部技术与安全US

COVID-19中的肺部超声:急性期之后的作用?

Lung Ultrasound in COVID-19 A Role Beyond the Acute Phase?
PubMed 文献 · J Ultrasound Med · 2020-08-08

该前瞻性研究纳入2020年4月6日至5月22日期间70例长期住院并接受住院康复的COVID-19患者,出院时行肺部超声评估。出院前肺部超声评分仍明显异常,急性期需通气支持者评分高于轻症者(中位数8.0 vs 2.0,P<.001),即使两组均符合国际出院标准。肺部超声可识别重症COVID-19患者符合出院标准时仍存在的亚临床残余肺损伤。

要点

  • COVID-19患者符合出院标准时肺部超声评分仍可明显异常,提示亚临床残余肺损伤。
  • 急性期需通气支持者出院前肺部超声评分中位数8.0,高于轻症者的2.0(P<.001)。
  • 作者认为肺部超声因低成本、易操作、无辐射,似乎适合门诊和初级保健随访。

核心结论

  • 肺部超声可识别重症COVID-19患者即使符合出院标准时仍持续存在的亚临床残余肺损伤。
  • 考虑到低成本、易应用和无辐射暴露,肺部超声似乎是门诊和初级保健机构用于COVID-19患者随访的理想工具。

研究设计与样本

  • 前瞻性研究,连续纳入70例COVID-19患者(22例女性、48例男性;平均年龄±SD,68±13岁),均为2020年4月6日至5月22日期间长期住院并接受住院康复者。
  • 所有患者出院时接受肺部超声评估,将急性期病情较重(即需要通气支持)者与病情较轻者的数据进行比较。

诊断标准与关键数值

  • 出院前肺部超声评分仍明显异常,急性期需通气支持者评分高于病情较轻者(中位数[四分位距],8.0[5.5-13.5] vs 2.0[1.0-7.0];P<.001),即使两类患者均符合国际定义的出院标准。

临床应用与阅片要点

  • 作者认为肺部超声似乎适合在门诊和初级保健机构用于COVID-19患者随访,理由是低成本、易应用和无辐射暴露。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Coronavirus disease 2019 (COVID-19) is a viral illness caused by severe acute respiratory syndrome coronavirus 2. With the increasing number of improved and discharged patients with COVID-19, the definition of an adequate follow-up strategy is needed. The purpose of this study was to assess whether lung ultrasound (LUS) is an effective indicator of subclinical residual lung damage in patients with COVID-19 who meet discharge criteria.

METHODS: We prospectively enrolled 70 consecutive patients with COVID-19 who had a prolonged hospitalization with inpatient rehabilitation between April 6 and May 22, 2020. All of the patients underwent an LUS evaluation at discharge. Data of patients with more severe disease during the acute phase (ie, required ventilatory support) were compared to those of patients with milder disease.

RESULTS: Among the 70 patients with COVID-19 (22 women and 48 men; mean age ± SD, 68 ± 13 years), the LUS score before discharge was still frankly pathologic and higher in patients who had more severe disease during the acute phase compared to patients with milder disease (median [interquartile range], 8.0 [5.5-13.5] versus 2.0 [1.0-7.0]; P < .001), even when both categories met internationally defined discharge criteria.

CONCLUSIONS: Lung ultrasound can identify the persistence of subclinical residual lung damage in patients with severe COVID-19 even if they meet discharge criteria. Considering the low cost, easy application, and lack of radiation exposure, LUS seems the ideal tool to be adopted in outpatient and primary care settings for the follow-up of patients with COVID-19.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Gaspardone C, Meloni C, Preda A, et al. Lung Ultrasound in COVID-19 A Role Beyond the Acute Phase? J Ultrasound Med. 2020. PMID: 32770687. doi:10.1002/jum.15425

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。